ACADIA Pharmaceuticals Inc.
ACAD
$27.44
$0.893.35%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 847.02M | 762.00M | 681.58M | 755.99M | 565.33M |
| Total Receivables | 139.44M | 119.69M | 113.71M | 104.70M | 110.36M |
| Inventory | 29.10M | 26.12M | 22.95M | 21.95M | 61.04M |
| Prepaid Expenses | 60.87M | 52.75M | 52.70M | 55.68M | 51.55M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 1.08B | 960.55M | 870.94M | 938.32M | 788.28M |
|
|
|||||
| Total Current Assets | 1.08B | 960.55M | 870.94M | 938.32M | 788.28M |
| Net Property, Plant & Equipment | 53.38M | 54.54M | 54.11M | 50.79M | 48.24M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 111.62M | 114.34M | 117.06M | 119.78M | 105.52M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 89.35M | 96.13M | 90.25M | 78.87M | 34.83M |
| Total Assets | 1.33B | 1.23B | 1.13B | 1.19B | 976.87M |
|
|
|||||
| Total Accounts Payable | 21.75M | 20.10M | 18.10M | 16.19M | 19.08M |
| Total Accrued Expenses | 323.05M | 298.23M | 264.02M | 254.44M | 236.33M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 11.78M | 11.69M | 11.37M | 9.96M | 8.95M |
| Total Finance Division Other Current Liabilities | -- | -- | 9.05M | 114.28M | 79.58M |
| Total Other Current Liabilities | -- | -- | 9.05M | 114.28M | 79.58M |
| Total Current Liabilities | 356.58M | 330.02M | 302.53M | 394.87M | 343.95M |
|
|
|||||
| Total Current Liabilities | 356.58M | 330.02M | 302.53M | 394.87M | 343.95M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 43.03M | 44.60M | 44.63M | 42.04M | 40.42M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 13.89M | 28.55M | 19.96M | 18.06M | 15.32M |
| Total Liabilities | 413.50M | 403.17M | 367.13M | 454.96M | 399.69M |
|
|
|||||
| Common Stock & APIC | 3.00B | 2.98B | 2.95B | 2.94B | 2.92B |
| Retained Earnings | -2.09B | -2.16B | -2.19B | -2.20B | -2.35B |
| Treasury Stock & Other | 989.00K | 406.00K | 437.00K | 292.00K | 858.00K |
| Total Common Equity | 917.27M | 822.38M | 765.24M | 732.79M | 577.18M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 917.27M | 822.38M | 765.24M | 732.79M | 577.18M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 917.27M | 822.38M | 765.24M | 732.79M | 577.18M |
|
|
|||||